Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults [NA]

View source ↗

Summary

A clinical trial is ongoing to evaluate nicotinamide mononucleotide supplementation for improving exercise tolerance in healthy older adults, and the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide Mononucleotide (nicotinamide mononucleotide)

Snippet

Sponsor: Scott Silveira | Conditions: Aging, Frailty | NA | Status: RECRUITING